Bio-scaffold startup Ventrix said today it has safely conducted a first-in-human trial of an injectable hydrogel to repair cardiac tissue in patients who have suffered a heart attack. The FDA-approved, Phase 1 trial is the first to test a hydrogel made from the natural scaffolding of cardiac muscle tissue, also known as extracellular matrix, or […]
Ventrix
Ventrix launches cardiac scaffolding trial
Cardiac bio-scaffold company Ventrix said it launched a trial of its VentriGel biomaterial scaffold designed to repair cardiac tissue in patients who’ve suffered a myocardial infarction. The phase 1, open-label trial is slated to enroll patients who’ve experienced their 1st myocardial infarction in the past 3 years and show signs of left ventricular dysfunction, according to […]